<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">34639180</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>10</Month>
        <Day>25</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>10</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1422-0067</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>22</Volume>
            <Issue>19</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Oct</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal of molecular sciences</Title>
          <ISOAbbreviation>Int J Mol Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Roles of Non-Canonical Wnt Signalling Pathways in Bone Biology.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">10840</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms221910840</ELocationID>
        <Abstract>
          <AbstractText>The Wnt signalling pathway is one of the central signalling pathways in bone development, homeostasis and regulation of bone mineral density. It consists of numerous Wnt ligands, receptors and co-receptors, which ensure tight spatiotemporal regulation of Wnt signalling pathway activity and thus tight regulation of bone tissue homeostasis. This enables maintenance of optimal mineral density, tissue healing and adaptation to changes in bone loading. While the role of the canonical/β-catenin Wnt signalling pathway in bone homeostasis is relatively well researched, Wnt ligands can also activate several non-canonical, β-catenin independent signalling pathways with important effects on bone tissue. In this review, we will provide a thorough overview of the current knowledge on different non-canonical Wnt signalling pathways involved in bone biology, focusing especially on the pathways that affect bone cell differentiation, maturation and function, processes involved in bone tissue structure regulation. We will describe the role of the two most known non-canonical pathways (Wnt/planar cell polarity pathways and Wnt/Ca<sup>2+</sup> pathway), as well as other signalling pathways with a strong role in bone biology that communicate with the Wnt signalling pathway through non-canonical Wnt signalling. Our goal is to bring additional attention to these still not well researched but important pathways in the regulation of bone biology in the hope of prompting additional research in the area of non-canonical Wnt signalling pathways.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lojk</LastName>
            <ForeName>Jasna</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Biochemistry, Faculty of Pharmacy, University of Ljubljana, 1000 Ljubljana, Slovenia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Marc</LastName>
            <ForeName>Janja</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Biochemistry, Faculty of Pharmacy, University of Ljubljana, 1000 Ljubljana, Slovenia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>University Clinical Center Ljubljana, Clinical Department of Clinical Chemistry and Biochemistry, 1000 Ljubljana, Slovenia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Int J Mol Sci</MedlineTA>
        <NlmUniqueID>101092791</NlmUniqueID>
        <ISSNLinking>1422-0067</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001842" MajorTopicYN="N">Bone and Bones</DescriptorName>
          <QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002454" MajorTopicYN="Y">Cell Differentiation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010012" MajorTopicYN="Y">Osteogenesis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D060449" MajorTopicYN="Y">Wnt Signaling Pathway</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">bone mineral density</Keyword>
        <Keyword MajorTopicYN="N">non-canonical Wnt signalling pathway</Keyword>
        <Keyword MajorTopicYN="N">osteogenesis</Keyword>
        <Keyword MajorTopicYN="N">signalling crosstalk</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest. The funders had no role in the design, the content or in the decision to publish this review.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>13</Day>
          <Hour>1</Hour>
          <Minute>5</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34639180</ArticleId>
        <ArticleId IdType="pmc">PMC8509327</ArticleId>
        <ArticleId IdType="doi">10.3390/ijms221910840</ArticleId>
        <ArticleId IdType="pii">ijms221910840</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Logan C.Y., Nusse R. The Wnt Signaling Pathway in Development and Disease. Annu. Rev. Cell Dev. Biol. 2004;20:781–810. doi: 10.1146/annurev.cellbio.20.010403.113126.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev.cellbio.20.010403.113126</ArticleId>
            <ArticleId IdType="pubmed">15473860</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Houschyar K.S., Tapking C., Borrelli M.R., Popp D., Duscher D., Maan Z.N., Chelliah M.P., Li J., Harati K., Wallner C., et al.  Wnt Pathway in Bone Repair and Regeneration—What Do We Know So Far. Front. Cell Dev. Biol. 2019;6:170. doi: 10.3389/fcell.2018.00170.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fcell.2018.00170</ArticleId>
            <ArticleId IdType="pmc">PMC6330281</ArticleId>
            <ArticleId IdType="pubmed">30666305</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhan T., Rindtorff N., Boutros M. Wnt Signaling in Cancer. Oncogene. 2017;36:1461–1473. doi: 10.1038/onc.2016.304.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/onc.2016.304</ArticleId>
            <ArticleId IdType="pmc">PMC5357762</ArticleId>
            <ArticleId IdType="pubmed">27617575</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aghaizu N.D., Jin H., Whiting P.J. Dysregulated Wnt Signalling in the Alzheimer’s Brain. Brain Sci. 2020;10:902.  doi: 10.3390/brainsci10120902.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/brainsci10120902</ArticleId>
            <ArticleId IdType="pmc">PMC7761504</ArticleId>
            <ArticleId IdType="pubmed">33255414</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abou Ziki M.D., Mani A. The Interplay of Canonical and Noncanonical Wnt Signaling in Metabolic Syndrome. Nutr. Res. 2019;70:18–25. doi: 10.1016/j.nutres.2018.06.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.nutres.2018.06.009</ArticleId>
            <ArticleId IdType="pmc">PMC6320319</ArticleId>
            <ArticleId IdType="pubmed">30049588</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen J., Ning C., Mu J., Li D., Ma Y., Meng X. Role of Wnt Signaling Pathways in Type 2 Diabetes Mellitus. Mol. Cell. Biochem. 2021;476:2219–2232. doi: 10.1007/s11010-021-04086-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11010-021-04086-5</ArticleId>
            <ArticleId IdType="pubmed">33566231</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kobayashi Y., Uehara S., Udagawa N., Takahashi N. Regulation of Bone Metabolism by Wnt Signals. J. Biochem. 2016;159:387–392. doi: 10.1093/jb/mvv124.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jb/mvv124</ArticleId>
            <ArticleId IdType="pmc">PMC4885935</ArticleId>
            <ArticleId IdType="pubmed">26711238</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krishnan V., Bryant H.U., Macdougald O.A. Regulation of Bone Mass by Wnt Signaling. J. Clin. Investig. 2006;116:1202–1209. doi: 10.1172/JCI28551.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI28551</ArticleId>
            <ArticleId IdType="pmc">PMC1451219</ArticleId>
            <ArticleId IdType="pubmed">16670761</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gong Y., Slee R.B., Fukai N., Rawadi G., Roman-Roman S., Reginato A.M., Wang H., Cundy T., Glorieux F.H., Lev D., et al.  LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development. Cell. 2001;107:513–523. doi: 10.1016/S0092-8674(01)00571-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0092-8674(01)00571-2</ArticleId>
            <ArticleId IdType="pubmed">11719191</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huybrechts Y., Mortier G., Boudin E., Van Hul W. WNT Signaling and Bone: Lessons From Skeletal Dysplasias and Disorders. Front. Endocrinol. 2020;11:165. doi: 10.3389/fendo.2020.00165.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fendo.2020.00165</ArticleId>
            <ArticleId IdType="pmc">PMC7160326</ArticleId>
            <ArticleId IdType="pubmed">32328030</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trajanoska K., Rivadeneira F. The Genetic Architecture of Osteoporosis and Fracture Risk. Bone. 2019;126:2–10. doi: 10.1016/j.bone.2019.04.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bone.2019.04.005</ArticleId>
            <ArticleId IdType="pubmed">30980960</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gallagher M.D., Chen-Plotkin A.S. The Post-GWAS Era: From Association to Function. Am. J. Hum. Genet. 2018;102:717–730. doi: 10.1016/j.ajhg.2018.04.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajhg.2018.04.002</ArticleId>
            <ArticleId IdType="pmc">PMC5986732</ArticleId>
            <ArticleId IdType="pubmed">29727686</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kato M., Patel M.S., Levasseur R., Lobov I., Chang B.H.-J., Glass D.A., Hartmann C., Li L., Hwang T.-H., Brayton C.F., et al.  Cbfa1-Independent Decrease in Osteoblast Proliferation, Osteopenia, and Persistent Embryonic Eye Vascularization in Mice Deficient in Lrp5, a Wnt Coreceptor. J. Cell Biol. 2002;157:303–314. doi: 10.1083/jcb.200201089.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.200201089</ArticleId>
            <ArticleId IdType="pmc">PMC2199263</ArticleId>
            <ArticleId IdType="pubmed">11956231</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Holmen S.L., Zylstra C.R., Mukherjee A., Sigler R.E., Faugere M.-C., Bouxsein M.L., Deng L., Clemens T.L., Williams B.O. Essential Role of Beta-Catenin in Postnatal Bone Acquisition. J. Biol. Chem. 2005;280:21162–21168. doi: 10.1074/jbc.M501900200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M501900200</ArticleId>
            <ArticleId IdType="pubmed">15802266</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hill T.P., Später D., Taketo M.M., Birchmeier W., Hartmann C. Canonical Wnt/Beta-Catenin Signaling Prevents Osteoblasts from Differentiating into Chondrocytes. Dev. Cell. 2005;8:727–738. doi: 10.1016/j.devcel.2005.02.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.devcel.2005.02.013</ArticleId>
            <ArticleId IdType="pubmed">15866163</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Day T.F., Guo X., Garrett-Beal L., Yang Y. Wnt/Beta-Catenin Signaling in Mesenchymal Progenitors Controls Osteoblast and Chondrocyte Differentiation during Vertebrate Skeletogenesis. Dev. Cell. 2005;8:739–750. doi: 10.1016/j.devcel.2005.03.016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.devcel.2005.03.016</ArticleId>
            <ArticleId IdType="pubmed">15866164</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Glass D.A., Bialek P., Ahn J.D., Starbuck M., Patel M.S., Clevers H., Taketo M.M., Long F., McMahon A.P., Lang R.A., et al.  Canonical Wnt Signaling in Differentiated Osteoblasts Controls Osteoclast Differentiation. Dev. Cell. 2005;8:751–764. doi: 10.1016/j.devcel.2005.02.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.devcel.2005.02.017</ArticleId>
            <ArticleId IdType="pubmed">15866165</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kramer I., Halleux C., Keller H., Pegurri M., Gooi J.H., Weber P.B., Feng J.Q., Bonewald L.F., Kneissel M. Osteocyte Wnt/Beta-Catenin Signaling Is Required for Normal Bone Homeostasis. Mol. Cell. Biol. 2010;30:3071–3085. doi: 10.1128/MCB.01428-09.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/MCB.01428-09</ArticleId>
            <ArticleId IdType="pmc">PMC2876685</ArticleId>
            <ArticleId IdType="pubmed">20404086</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maeda K., Kobayashi Y., Udagawa N., Uehara S., Ishihara A., Mizoguchi T., Kikuchi Y., Takada I., Kato S., Kani S., et al.  Wnt5a-Ror2 Signaling between Osteoblast-Lineage Cells and Osteoclast Precursors Enhances Osteoclastogenesis. Nat. Med. 2012;18:405–412. doi: 10.1038/nm.2653.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.2653</ArticleId>
            <ArticleId IdType="pubmed">22344299</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zeng X., Huang H., Tamai K., Zhang X., Harada Y., Yokota C., Almeida K., Wang J., Doble B., Woodgett J., et al.  Initiation of Wnt Signaling: Control of Wnt Coreceptor Lrp6 Phosphorylation/Activation via Frizzled, Dishevelled and Axin Functions. Development. 2008;135:367–375. doi: 10.1242/dev.013540.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.013540</ArticleId>
            <ArticleId IdType="pmc">PMC5328672</ArticleId>
            <ArticleId IdType="pubmed">18077588</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bienz M. Signalosome Assembly by Domains Undergoing Dynamic Head-to-Tail Polymerization. Trends Biochem. Sci. 2014;39:487–495. doi: 10.1016/j.tibs.2014.08.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tibs.2014.08.006</ArticleId>
            <ArticleId IdType="pubmed">25239056</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fiedler M., Graeb M., Mieszczanek J., Rutherford T.J., Johnson C.M., Bienz M. An Ancient Pygo-Dependent Wnt Enhanceosome Integrated by Chip/LDB-SSDP. eLife. 2015;4:e09073. doi: 10.7554/eLife.09073.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7554/eLife.09073</ArticleId>
            <ArticleId IdType="pmc">PMC4571689</ArticleId>
            <ArticleId IdType="pubmed">26312500</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sekiya T., Zaret K.S. Repression by Groucho/TLE/Grg Proteins: Genomic Site Recruitment Generates Compacted Chromatin in Vitro and Impairs Activator Binding in Vivo. Mol. Cell. 2007;28:291–303. doi: 10.1016/j.molcel.2007.10.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molcel.2007.10.002</ArticleId>
            <ArticleId IdType="pmc">PMC2083644</ArticleId>
            <ArticleId IdType="pubmed">17964267</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arce L., Yokoyama N.N., Waterman M.L. Diversity of LEF/TCF Action in Development and Disease. Oncogene. 2006;25:7492–7504. doi: 10.1038/sj.onc.1210056.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.onc.1210056</ArticleId>
            <ArticleId IdType="pubmed">17143293</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Turki-Judeh W., Courey A.J. Groucho: A Corepressor with Instructive Roles in Development. Curr. Top. Dev. Biol. 2012;98:65–96. doi: 10.1016/B978-0-12-386499-4.00003-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/B978-0-12-386499-4.00003-3</ArticleId>
            <ArticleId IdType="pubmed">22305159</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Veeman M.T., Axelrod J.D., Moon R.T. A Second Canon. Functions and Mechanisms of Beta-Catenin-Independent Wnt Signaling. Dev. Cell. 2003;5:367–377. doi: 10.1016/S1534-5807(03)00266-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1534-5807(03)00266-1</ArticleId>
            <ArticleId IdType="pubmed">12967557</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mikels A.J., Nusse R. Purified Wnt5a Protein Activates or Inhibits Beta-Catenin-TCF Signaling Depending on Receptor Context. PLoS Biol. 2006;4:e115.  doi: 10.1371/journal.pbio.0040115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pbio.0040115</ArticleId>
            <ArticleId IdType="pmc">PMC1420652</ArticleId>
            <ArticleId IdType="pubmed">16602827</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Van Amerongen R., Fuerer C., Mizutani M., Nusse R. Wnt5a Can Both Activate and Repress Wnt/β-Catenin Signaling during Mouse Embryonic Development. Dev. Biol. 2012;369:101–114. doi: 10.1016/j.ydbio.2012.06.020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ydbio.2012.06.020</ArticleId>
            <ArticleId IdType="pmc">PMC3435145</ArticleId>
            <ArticleId IdType="pubmed">22771246</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nalesso G., Sherwood J., Bertrand J., Pap T., Ramachandran M., De Bari C., Pitzalis C., Dell’Accio F. WNT-3A Modulates Articular Chondrocyte Phenotype by Activating Both Canonical and Noncanonical Pathways. J Cell Biol. 2011;193:551–564. doi: 10.1083/jcb.201011051.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.201011051</ArticleId>
            <ArticleId IdType="pmc">PMC3087013</ArticleId>
            <ArticleId IdType="pubmed">21536751</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grumolato L., Liu G., Mong P., Mudbhary R., Biswas R., Arroyave R., Vijayakumar S., Economides A.N., Aaronson S.A. Canonical and Noncanonical Wnts Use a Common Mechanism to Activate Completely Unrelated Coreceptors. Genes Dev. 2010;24:2517–2530. doi: 10.1101/gad.1957710.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gad.1957710</ArticleId>
            <ArticleId IdType="pmc">PMC2975928</ArticleId>
            <ArticleId IdType="pubmed">21078818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qiu W., Chen L., Kassem M. Activation of Non-Canonical Wnt/JNK Pathway by Wnt3a Is Associated with Differentiation Fate Determination of Human Bone Marrow Stromal (Mesenchymal) Stem Cells. Biochem. Biophys. Res. Commun. 2011;413:98–104. doi: 10.1016/j.bbrc.2011.08.061.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2011.08.061</ArticleId>
            <ArticleId IdType="pubmed">21875572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Almeida M., Han L., Bellido T., Manolagas S.C., Kousteni S. Wnt Proteins Prevent Apoptosis of Both Uncommitted Osteoblast Progenitors and Differentiated Osteoblasts by β-Catenin-Dependent and -Independent Signaling Cascades Involving Src/ERK and Phosphatidylinositol 3-Kinase/AKT. J. Biol. Chem. 2005;280:41342–41351. doi: 10.1074/jbc.M502168200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M502168200</ArticleId>
            <ArticleId IdType="pubmed">16251184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weidinger G., Moon R.T. When Wnts Antagonize Wnts. J. Cell Biol. 2003;162:753–756. doi: 10.1083/jcb.200307181.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.200307181</ArticleId>
            <ArticleId IdType="pmc">PMC2172824</ArticleId>
            <ArticleId IdType="pubmed">12952929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baksh D., Boland G.M., Tuan R.S. Cross-Talk between Wnt Signaling Pathways in Human Mesenchymal Stem Cells Leads to Functional Antagonism during Osteogenic Differentiation. J. Cell. Biochem. 2007;101:1109–1124. doi: 10.1002/jcb.21097.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcb.21097</ArticleId>
            <ArticleId IdType="pubmed">17546602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Van Amerongen R., Mikels A., Nusse R. Alternative Wnt Signaling Is Initiated by Distinct Receptors. Sci. Signal. 2008;1:re9. doi: 10.1126/scisignal.135re9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/scisignal.135re9</ArticleId>
            <ArticleId IdType="pubmed">18765832</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Quarto N., Behr B., Longaker M.T. Opposite Spectrum of Activity of Canonical Wnt Signaling in the Osteogenic Context of Undifferentiated and Differentiated Mesenchymal Cells: Implications for Tissue Engineering. Tissue Eng. Part A. 2010;16:3185–3197. doi: 10.1089/ten.tea.2010.0133.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/ten.tea.2010.0133</ArticleId>
            <ArticleId IdType="pmc">PMC2947420</ArticleId>
            <ArticleId IdType="pubmed">20590472</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hsieh J.-C., Rattner A., Smallwood P.M., Nathans J. Biochemical Characterization of Wnt-Frizzled Interactions Using a Soluble, Biologically Active Vertebrate Wnt Protein. Proc. Natl. Acad. Sci. USA. 1999;96:3546–3551. doi: 10.1073/pnas.96.7.3546.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.96.7.3546</ArticleId>
            <ArticleId IdType="pmc">PMC22330</ArticleId>
            <ArticleId IdType="pubmed">10097073</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu C., Nusse R. Ligand Receptor Interactions in the Wnt Signaling Pathway InDrosophila. J. Biol. Chem. 2002;277:41762–41769. doi: 10.1074/jbc.M207850200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M207850200</ArticleId>
            <ArticleId IdType="pubmed">12205098</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rulifson E.J., Wu C.H., Nusse R. Pathway Specificity by the Bifunctional Receptor Frizzled Is Determined by Affinity for Wingless. Mol. Cell. 2000;6:117–126. doi: 10.1016/S1097-2765(05)00018-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1097-2765(05)00018-3</ArticleId>
            <ArticleId IdType="pubmed">10949033</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y., Chang H., Rattner A., Nathans J. Frizzled Receptors in Development and Disease. Curr. Top. Dev. Biol. 2016;117:113–139. doi: 10.1016/bs.ctdb.2015.11.028.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/bs.ctdb.2015.11.028</ArticleId>
            <ArticleId IdType="pmc">PMC5103317</ArticleId>
            <ArticleId IdType="pubmed">26969975</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kushwaha P., Kim S., Foxa G.E., Michalski M.N., Williams B.O., Tomlinson R.E., Riddle R.C. Frizzled-4 Is Required for Normal Bone Acquisition despite Compensation by Frizzled-8. J. Cell. Physiol. 2020;235:6673–6683. doi: 10.1002/jcp.29563.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcp.29563</ArticleId>
            <ArticleId IdType="pmc">PMC7382978</ArticleId>
            <ArticleId IdType="pubmed">31985040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Y., Bhat R.A., Seestaller-Wehr L.M., Fukayama S., Mangine A., Moran R.A., Komm B.S., Bodine P.V.N., Billiard J. The Orphan Receptor Tyrosine Kinase Ror2 Promotes Osteoblast Differentiation and Enhances Ex Vivo Bone Formation. Mol. Endocrinol. 2007;21:376–387. doi: 10.1210/me.2006-0342.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/me.2006-0342</ArticleId>
            <ArticleId IdType="pubmed">17095577</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Billiard J., Way D.S., Seestaller-Wehr L.M., Moran R.A., Mangine A., Bodine P.V.N. The Orphan Receptor Tyrosine Kinase Ror2 Modulates Canonical Wnt Signaling in Osteoblastic Cells. Mol. Endocrinol. 2005;19:90–101. doi: 10.1210/me.2004-0153.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/me.2004-0153</ArticleId>
            <ArticleId IdType="pubmed">15388793</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saldanha J., Singh J., Mahadevan D. Identification of a Frizzled-like Cysteine Rich Domain in the Extracellular Region of Developmental Receptor Tyrosine Kinases. Protein Sci. 1998;7:1632–1635. doi: 10.1002/pro.5560070718.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/pro.5560070718</ArticleId>
            <ArticleId IdType="pmc">PMC2144063</ArticleId>
            <ArticleId IdType="pubmed">9684897</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Semënov M., Tamai K., He X. SOST Is a Ligand for LRP5/LRP6 and a Wnt Signaling Inhibitor. J. Biol. Chem. 2005;280:26770–26775. doi: 10.1074/jbc.M504308200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M504308200</ArticleId>
            <ArticleId IdType="pubmed">15908424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li X., Zhang Y., Kang H., Liu W., Liu P., Zhang J., Harris S.E., Wu D. Sclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling. J. Biol. Chem. 2005;280:19883–19887. doi: 10.1074/jbc.M413274200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M413274200</ArticleId>
            <ArticleId IdType="pubmed">15778503</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mao B., Wu W., Li Y., Hoppe D., Stannek P., Glinka A., Niehrs C. LDL-Receptor-Related Protein 6 Is a Receptor for Dickkopf Proteins. Nature. 2001;411:321–325. doi: 10.1038/35077108.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/35077108</ArticleId>
            <ArticleId IdType="pubmed">11357136</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bafico A., Liu G., Yaniv A., Gazit A., Aaronson S.A. Novel Mechanism of Wnt Signalling Inhibition Mediated by Dickkopf-1 Interaction with LRP6/Arrow. Nat. Cell Biol. 2001;3:683–686. doi: 10.1038/35083081.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/35083081</ArticleId>
            <ArticleId IdType="pubmed">11433302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Semënov M.V., Zhang X., He X. DKK1 Antagonizes Wnt Signaling without Promotion of LRP6 Internalization and Degradation. J. Biol. Chem. 2008;283:21427–21432. doi: 10.1074/jbc.M800014200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M800014200</ArticleId>
            <ArticleId IdType="pmc">PMC2490777</ArticleId>
            <ArticleId IdType="pubmed">18505732</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin K., Wang S., Julius M.A., Kitajewski J., Moos M., Luyten F.P. The Cysteine-Rich Frizzled Domain of Frzb-1 Is Required and Sufficient for Modulation of Wnt Signaling. Proc. Natl. Acad. Sci. USA. 1997;94:11196–11200. doi: 10.1073/pnas.94.21.11196.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.94.21.11196</ArticleId>
            <ArticleId IdType="pmc">PMC23413</ArticleId>
            <ArticleId IdType="pubmed">9326585</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bhat R.A., Stauffer B., Komm B.S., Bodine P.V.N. Structure–Function Analysis of Secreted Frizzled-Related Protein-1 for Its Wnt Antagonist Function. J. Cell. Biochem. 2007;102:1519–1528. doi: 10.1002/jcb.21372.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcb.21372</ArticleId>
            <ArticleId IdType="pubmed">17471511</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cho S.W., Yang J.-Y., Sun H.J., Jung J.Y., Her S.J., Cho H.Y., Choi H.J., Kim S.W., Kim S.Y., Shin C.S. Wnt Inhibitory Factor (WIF)-1 Inhibits Osteoblastic Differentiation in Mouse Embryonic Mesenchymal Cells. Bone. 2009;44:1069–1077. doi: 10.1016/j.bone.2009.02.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bone.2009.02.012</ArticleId>
            <ArticleId IdType="pubmed">19254785</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mii Y., Taira M. Secreted Frizzled-Related Proteins Enhance the Diffusion of Wnt Ligands and Expand Their Signalling Range. Development. 2009;136:4083–4088. doi: 10.1242/dev.032524.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.032524</ArticleId>
            <ArticleId IdType="pubmed">19906850</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Üren A., Reichsman F., Anest V., Taylor W.G., Muraiso K., Bottaro D.P., Cumberledge S., Rubin J.S. Secreted Frizzled-Related Protein-1 Binds Directly to Wingless and Is a Biphasic Modulator of Wnt Signaling. J. Biol. Chem. 2000;275:4374–4382. doi: 10.1074/jbc.275.6.4374.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.275.6.4374</ArticleId>
            <ArticleId IdType="pubmed">10660608</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baron R., Kneissel M. WNT Signaling in Bone Homeostasis and Disease: From Human Mutations to Treatments. Nat. Med. 2013;19:179–192. doi: 10.1038/nm.3074.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.3074</ArticleId>
            <ArticleId IdType="pubmed">23389618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu G., Vijayakumar S., Grumolato L., Arroyave R., Qiao H., Akiri G., Aaronson S.A. Canonical Wnts Function as Potent Regulators of Osteogenesis by Human Mesenchymal Stem Cells. J. Cell Biol. 2009;185:67–75. doi: 10.1083/jcb.200810137.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.200810137</ArticleId>
            <ArticleId IdType="pmc">PMC2700509</ArticleId>
            <ArticleId IdType="pubmed">19349579</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Joeng K.S., Lee Y.-C., Lim J., Chen Y., Jiang M.-M., Munivez E., Ambrose C., Lee B.H. Osteocyte-Specific WNT1 Regulates Osteoblast Function during Bone Homeostasis. J. Clin. Investig. 2017;127:2678–2688. doi: 10.1172/JCI92617.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI92617</ArticleId>
            <ArticleId IdType="pmc">PMC5490765</ArticleId>
            <ArticleId IdType="pubmed">28628032</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jia B., Wang Z., Sun X., Chen J., Zhao J., Qiu X. Long Noncoding RNA LINC00707 Sponges MiR-370-3p to Promote Osteogenesis of Human Bone Marrow-Derived Mesenchymal Stem Cells through Upregulating WNT2B. Stem Cell Res. 2019;10:67. doi: 10.1186/s13287-019-1161-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13287-019-1161-9</ArticleId>
            <ArticleId IdType="pmc">PMC6387535</ArticleId>
            <ArticleId IdType="pubmed">30795799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mak W., Shao X., Dunstan C.R., Seibel M.J., Zhou H. Biphasic Glucocorticoid-Dependent Regulation of Wnt Expression and Its Inhibitors in Mature Osteoblastic Cells. Calcif. Tissue Int. 2009;85:538–545. doi: 10.1007/s00223-009-9303-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00223-009-9303-1</ArticleId>
            <ArticleId IdType="pubmed">19876584</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weivoda M.M., Ruan M., Hachfeld C.M., Pederson L., Howe A., Davey R.A., Zajac J.D., Kobayashi Y., Williams B.O., Westendorf J.J., et al.  Wnt Signaling Inhibits Osteoclast Differentiation by Activating Canonical and Noncanonical CAMP/PKA Pathways. J. Bone Miner. Res. 2016;31:65–75. doi: 10.1002/jbmr.2599.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jbmr.2599</ArticleId>
            <ArticleId IdType="pmc">PMC4758681</ArticleId>
            <ArticleId IdType="pubmed">26189772</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boland G.M., Perkins G., Hall D.J., Tuan R.S. Wnt 3a Promotes Proliferation and Suppresses Osteogenic Differentiation of Adult Human Mesenchymal Stem Cells. J. Cell. Biochem. 2004;93:1210–1230. doi: 10.1002/jcb.20284.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcb.20284</ArticleId>
            <ArticleId IdType="pubmed">15486964</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Boer J., Siddappa R., Gaspar C., van Apeldoorn A., Fodde R., van Blitterswijk C. Wnt Signaling Inhibits Osteogenic Differentiation of Human Mesenchymal Stem Cells. Bone. 2004;34:818–826. doi: 10.1016/j.bone.2004.01.016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bone.2004.01.016</ArticleId>
            <ArticleId IdType="pubmed">15121013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cho H.H., Kim Y.J., Kim S.J., Kim J.H., Bae Y.C., Ba B., Jung J.S. Endogenous Wnt Signaling Promotes Proliferation and Suppresses Osteogenic Differentiation in Human Adipose Derived Stromal Cells. Tissue Eng. 2006;12:111–121. doi: 10.1089/ten.2006.12.111.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/ten.2006.12.111</ArticleId>
            <ArticleId IdType="pubmed">16499448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Keller K.C., Ding H., Tieu R., Sparks N.R.L., Ehnes D.D., Zur Nieden N.I. Wnt5a Supports Osteogenic Lineage Decisions in Embryonic Stem Cells. Stem Cells Dev. 2016;25:1020–1032. doi: 10.1089/scd.2015.0367.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/scd.2015.0367</ArticleId>
            <ArticleId IdType="pubmed">26956615</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shen J., Chen X., Jia H., Meyers C.A., Shrestha S., Asatrian G., Ding C., Tsuei R., Zhang X., Peault B., et al.  Effects of WNT3A and WNT16 on the Osteogenic and Adipogenic Differentiation of Perivascular Stem/Stromal Cells. Tissue Eng. Part A. 2018;24:68–80. doi: 10.1089/ten.tea.2016.0387.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/ten.tea.2016.0387</ArticleId>
            <ArticleId IdType="pmc">PMC5770092</ArticleId>
            <ArticleId IdType="pubmed">28463594</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tu X., Joeng K.S., Nakayama K.I., Nakayama K., Rajagopal J., Carroll T.J., McMahon A.P., Long F. Noncanonical Wnt Signaling through G Protein-Linked PKCδ Activation Promotes Bone Formation. Dev. Cell. 2007;12:113–127. doi: 10.1016/j.devcel.2006.11.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.devcel.2006.11.003</ArticleId>
            <ArticleId IdType="pmc">PMC1861818</ArticleId>
            <ArticleId IdType="pubmed">17199045</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hamamura K., Chen A., Nishimura A., Tanjung N., Sudo A., Yokota H. Predicting and Validating the Pathway of Wnt3a-Driven Suppression of Osteoclastogenesis. Cell. Signal. 2014;26:2358–2369. doi: 10.1016/j.cellsig.2014.07.018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cellsig.2014.07.018</ArticleId>
            <ArticleId IdType="pmc">PMC4187210</ArticleId>
            <ArticleId IdType="pubmed">25038457</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karner C.M., Esen E., Okunade A.L., Patterson B.W., Long F. Increased Glutamine Catabolism Mediates Bone Anabolism in Response to WNT Signaling. J. Clin. Investig. 2015;125:551–562. doi: 10.1172/JCI78470.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI78470</ArticleId>
            <ArticleId IdType="pmc">PMC4319407</ArticleId>
            <ArticleId IdType="pubmed">25562323</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Esen E., Chen J., Karner C.M., Okunade A.L., Patterson B.W., Long F. WNT-LRP5 Signaling Induces Warburg Effect through MTORC2 Activation during Osteoblast Differentiation. Cell Metab. 2013;17:745–755. doi: 10.1016/j.cmet.2013.03.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2013.03.017</ArticleId>
            <ArticleId IdType="pmc">PMC3653292</ArticleId>
            <ArticleId IdType="pubmed">23623748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hwang S.-G., Yu S.-S., Lee S.-W., Chun J.-S. Wnt-3a Regulates Chondrocyte Differentiation via c-Jun/AP-1 Pathway. FEBS Lett. 2005;579:4837–4842. doi: 10.1016/j.febslet.2005.07.067.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.febslet.2005.07.067</ArticleId>
            <ArticleId IdType="pubmed">16099458</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rossol-Allison J., Stemmle L.N., Swenson-Fields K.I., Kelly P., Fields P.E., McCall S.J., Casey P.J., Fields T.A. RHO GTPASE activity modulates WNT3A/β-catenin signaling. Cell. Signal. 2009;21:1559–1568. doi: 10.1016/j.cellsig.2009.05.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cellsig.2009.05.010</ArticleId>
            <ArticleId IdType="pmc">PMC2735600</ArticleId>
            <ArticleId IdType="pubmed">19482078</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chang J., Sonoyama W., Wang Z., Jin Q., Zhang C., Krebsbach P.H., Giannobile W., Shi S., Wang C.-Y. Noncanonical Wnt-4 Signaling Enhances Bone Regeneration of Mesenchymal Stem Cells in Craniofacial Defects through Activation of P38 MAPK. J. Biol. Chem. 2007;282:30938–30948. doi: 10.1074/jbc.M702391200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M702391200</ArticleId>
            <ArticleId IdType="pubmed">17720811</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu B., Chang J., Liu Y., Li J., Kevork K., Al-Hezaimi K., Graves D.T., Park N.-H., Wang C.-Y. Wnt4 Signaling Prevents Skeletal Aging and Inflammation by Inhibiting Nuclear Factor-ΚB. Nat. Med. 2014;20:1009–1017. doi: 10.1038/nm.3586.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.3586</ArticleId>
            <ArticleId IdType="pmc">PMC4159424</ArticleId>
            <ArticleId IdType="pubmed">25108526</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Uehara S., Udagawa N., Mukai H., Ishihara A., Maeda K., Yamashita T., Murakami K., Nishita M., Nakamura T., Kato S., et al.  Protein Kinase N3 Promotes Bone Resorption by Osteoclasts in Response to Wnt5a-Ror2 Signaling. Sci. Signal. 2017;10:eaan0023. doi: 10.1126/scisignal.aan0023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/scisignal.aan0023</ArticleId>
            <ArticleId IdType="pubmed">28851822</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ishitani T., Kishida S., Hyodo-Miura J., Ueno N., Yasuda J., Waterman M., Shibuya H., Moon R.T., Ninomiya-Tsuji J., Matsumoto K. The TAK1-NLK Mitogen-Activated Protein Kinase Cascade Functions in the Wnt-5a/Ca2+ Pathway To Antagonize Wnt/β-Catenin Signaling. Mol. Cell. Biol. 2003;23:131–139. doi: 10.1128/MCB.23.1.131-139.2003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/MCB.23.1.131-139.2003</ArticleId>
            <ArticleId IdType="pmc">PMC140665</ArticleId>
            <ArticleId IdType="pubmed">12482967</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bradley E.W., Drissi M.H. WNT5A Regulates Chondrocyte Differentiation through Differential Use of the CaN/NFAT and IKK/NF-ΚB Pathways. Mol. Endocrinol. 2010;24:1581–1593. doi: 10.1210/me.2010-0037.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/me.2010-0037</ArticleId>
            <ArticleId IdType="pmc">PMC5417459</ArticleId>
            <ArticleId IdType="pubmed">20573686</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arnsdorf E.J., Tummala P., Jacobs C.R. Non-Canonical Wnt Signaling and N-Cadherin Related β-Catenin Signaling Play a Role in Mechanically Induced Osteogenic Cell Fate. PLoS ONE. 2009;4:e5388.  doi: 10.1371/journal.pone.0005388.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0005388</ArticleId>
            <ArticleId IdType="pmc">PMC2670536</ArticleId>
            <ArticleId IdType="pubmed">19401766</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bilkovski R., Schulte D.M., Oberhauser F., Gomolka M., Udelhoven M., Hettich M.M., Roth B., Heidenreich A., Gutschow C., Krone W., et al.  Role of WNT-5a in the Determination of Human Mesenchymal Stem Cells into Preadipocytes. J. Biol. Chem. 2010;285:6170–6178. doi: 10.1074/jbc.M109.054338.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M109.054338</ArticleId>
            <ArticleId IdType="pmc">PMC2825412</ArticleId>
            <ArticleId IdType="pubmed">20032469</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bradley E.W., Drissi M.H. Wnt5b Regulates Mesenchymal Cell Aggregation and Chondrocyte Differentiation through the Planar Cell Polarity Pathway. J. Cell. Physiol. 2011;226:1683–1693. doi: 10.1002/jcp.22499.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcp.22499</ArticleId>
            <ArticleId IdType="pubmed">21413026</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen J., Tu X., Esen E., Joeng K.S., Lin C., Arbeit J.M., Rüegg M.A., Hall M.N., Ma L., Long F. WNT7B Promotes Bone Formation in Part through MTORC1. PLoS Genet. 2014;10:e1004145.  doi: 10.1371/journal.pgen.1004145.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pgen.1004145</ArticleId>
            <ArticleId IdType="pmc">PMC3907335</ArticleId>
            <ArticleId IdType="pubmed">24497849</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bennett C.N., Ouyang H., Ma Y.L., Zeng Q., Gerin I., Sousa K.M., Lane T.F., Krishnan V., Hankenson K.D., MacDougald O.A. Wnt10b Increases Postnatal Bone Formation by Enhancing Osteoblast Differentiation. J. Bone Miner. Res. 2007;22:1924–1932. doi: 10.1359/jbmr.070810.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1359/jbmr.070810</ArticleId>
            <ArticleId IdType="pubmed">17708715</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bennett C.N., Longo K.A., Wright W.S., Suva L.J., Lane T.F., Hankenson K.D., MacDougald O.A. Regulation of Osteoblastogenesis and Bone Mass by Wnt10b. Proc. Natl. Acad. Sci. USA. 2005;102:3324–3329. doi: 10.1073/pnas.0408742102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0408742102</ArticleId>
            <ArticleId IdType="pmc">PMC552924</ArticleId>
            <ArticleId IdType="pubmed">15728361</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cawthorn W.P., Bree A.J., Yao Y., Du B., Hemati N., Martinez-Santibañez G., MacDougald O.A. Wnt6, Wnt10a and Wnt10b Inhibit Adipogenesis and Stimulate Osteoblastogenesis through a β-Catenin-Dependent Mechanism. Bone. 2012;50:477–489. doi: 10.1016/j.bone.2011.08.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bone.2011.08.010</ArticleId>
            <ArticleId IdType="pmc">PMC3261372</ArticleId>
            <ArticleId IdType="pubmed">21872687</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou H., Mak W., Zheng Y., Dunstan C.R., Seibel M.J. Osteoblasts Directly Control Lineage Commitment of Mesenchymal Progenitor Cells through Wnt Signaling. J. Biol. Chem. 2008;283:1936–1945. doi: 10.1074/jbc.M702687200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M702687200</ArticleId>
            <ArticleId IdType="pubmed">18045882</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kang S., Bennett C.N., Gerin I., Rapp L.A., Hankenson K.D., MacDougald O.A. Wnt Signaling Stimulates Osteoblastogenesis of Mesenchymal Precursors by Suppressing CCAAT/Enhancer-Binding Protein α and Peroxisome Proliferator-Activated Receptor γ. J. Biol. Chem. 2007;282:14515–14524. doi: 10.1074/jbc.M700030200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M700030200</ArticleId>
            <ArticleId IdType="pubmed">17351296</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Movérare-Skrtic S., Henning P., Liu X., Nagano K., Saito H., Börjesson A.E., Sjögren K., Windahl S.H., Farman H., Kindlund B., et al.  Osteoblast-Derived WNT16 Represses Osteoclastogenesis and Prevents Cortical Bone Fragility Fractures. Nat. Med. 2014;20:1279–1288. doi: 10.1038/nm.3654.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.3654</ArticleId>
            <ArticleId IdType="pmc">PMC4392888</ArticleId>
            <ArticleId IdType="pubmed">25306233</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kühl M., Sheldahl L.C., Park M., Miller J.R., Moon R.T. The Wnt/Ca2+ Pathway: A New Vertebrate Wnt Signaling Pathway Takes Shape. Trends Genet. 2000;16:279–283. doi: 10.1016/S0168-9525(00)02028-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0168-9525(00)02028-X</ArticleId>
            <ArticleId IdType="pubmed">10858654</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Q., Symes A.J., Kane C.A., Freeman A., Nariculam J., Munson P., Thrasivoulou C., Masters J.R.W., Ahmed A. A Novel Role for Wnt/Ca2+ Signaling in Actin Cytoskeleton Remodeling and Cell Motility in Prostate Cancer. PLoS ONE. 2010;5:e10456.  doi: 10.1371/journal.pone.0010456.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0010456</ArticleId>
            <ArticleId IdType="pmc">PMC2864254</ArticleId>
            <ArticleId IdType="pubmed">20454608</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kühl M., Sheldahl L.C., Malbon C.C., Moon R.T. Ca(2+)/Calmodulin-Dependent Protein Kinase II Is Stimulated by Wnt and Frizzled Homologs and Promotes Ventral Cell Fates in Xenopus. J. Biol. Chem. 2000;275:12701–12711. doi: 10.1074/jbc.275.17.12701.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.275.17.12701</ArticleId>
            <ArticleId IdType="pubmed">10777564</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Freisinger C.M., Fisher R.A., Slusarski D.C. Regulator of G Protein Signaling 3 Modulates Wnt5b Calcium Dynamics and Somite Patterning. PLoS Genet. 2010;6:e1001020.  doi: 10.1371/annotation/ab818270-c8c1-4d5d-8acf-ebad6e1d5c26.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/annotation/ab818270-c8c1-4d5d-8acf-ebad6e1d5c26</ArticleId>
            <ArticleId IdType="pmc">PMC2900303</ArticleId>
            <ArticleId IdType="pubmed">20628572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thrasivoulou C., Millar M., Ahmed A. Activation of Intracellular Calcium by Multiple Wnt Ligands and Translocation of β-Catenin into the Nucleus: A convergent model OF Wnt/Ca2+ AND Wnt/β-catenin pathways. J. Biol. Chem. 2013;288:35651–35659. doi: 10.1074/jbc.M112.437913.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M112.437913</ArticleId>
            <ArticleId IdType="pmc">PMC3861617</ArticleId>
            <ArticleId IdType="pubmed">24158438</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oishi I., Suzuki H., Onishi N., Takada R., Kani S., Ohkawara B., Koshida I., Suzuki K., Yamada G., Schwabe G.C., et al.  The Receptor Tyrosine Kinase Ror2 Is Involved in Non-Canonical Wnt5a/JNK Signalling Pathway. Genes Cells. 2003;8:645–654. doi: 10.1046/j.1365-2443.2003.00662.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1365-2443.2003.00662.x</ArticleId>
            <ArticleId IdType="pubmed">12839624</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blumenthal A., Ehlers S., Lauber J., Buer J., Lange C., Goldmann T., Heine H., Brandt E., Reiling N. The Wingless Homolog WNT5A and Its Receptor Frizzled-5 Regulate Inflammatory Responses of Human Mononuclear Cells Induced by Microbial Stimulation. Blood. 2006;108:965–973. doi: 10.1182/blood-2005-12-5046.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2005-12-5046</ArticleId>
            <ArticleId IdType="pubmed">16601243</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gu Q., Tian H., Zhang K., Chen D., Chen D., Wang X., Zhao J. Wnt5a/FZD4 Mediates the Mechanical Stretch-Induced Osteogenic Differentiation of Bone Mesenchymal Stem Cells. Cell. Physiol. Biochem. 2018;48:215–226. doi: 10.1159/000491721.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000491721</ArticleId>
            <ArticleId IdType="pubmed">30007964</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu X., Chen W., Zhou Y., Tang K., Zhang J. Mechanical Tension Promotes the Osteogenic Differentiation of Rat Tendon-Derived Stem Cells Through the Wnt5a/Wnt5b/JNK Signaling Pathway. Cell. Physiol. Biochem. 2015;36:517–530. doi: 10.1159/000430117.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000430117</ArticleId>
            <ArticleId IdType="pubmed">25966835</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Westendorf J.J., Kahler R.A., Schroeder T.M. Wnt Signaling in Osteoblasts and Bone Diseases. Gene. 2004;341:19–39. doi: 10.1016/j.gene.2004.06.044.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.gene.2004.06.044</ArticleId>
            <ArticleId IdType="pubmed">15474285</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Slusarski D.C., Yang-Snyder J., Busa W.B., Moon R.T. Modulation of Embryonic Intracellular Ca2+ Signaling by Wnt-5A. Dev. Biol. 1997;182:114–120. doi: 10.1006/dbio.1996.8463.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1006/dbio.1996.8463</ArticleId>
            <ArticleId IdType="pubmed">9073455</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Slusarski D.C., Corces V.G., Moon R.T. Interaction of Wnt and a Frizzled Homologue Triggers G-Protein-Linked Phosphatidylinositol Signalling. Nature. 1997;390:410–413. doi: 10.1038/37138.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/37138</ArticleId>
            <ArticleId IdType="pubmed">9389482</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sheldahl L.C., Park M., Malbon C.C., Moon R.T. Protein Kinase C Is Differentially Stimulated by Wnt and Frizzled Homologs in AG-Protein-Dependent Manner. Curr. Biol. 1999;9:695–698. doi: 10.1016/S0960-9822(99)80310-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0960-9822(99)80310-8</ArticleId>
            <ArticleId IdType="pubmed">10395542</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clapham D.E. Calcium Signaling. Cell. 2007;131:1047–1058. doi: 10.1016/j.cell.2007.11.028.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2007.11.028</ArticleId>
            <ArticleId IdType="pubmed">18083096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Batoon L., Millard S.M., Raggatt L.J., Pettit A.R. Osteomacs and Bone Regeneration. Curr. Osteoporos. Rep. 2017;15:385–395. doi: 10.1007/s11914-017-0384-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11914-017-0384-x</ArticleId>
            <ArticleId IdType="pubmed">28647885</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sinder B.P., Pettit A.R., McCauley L.K. Macrophages: Their Emerging Roles in Bone. J. Bone Min. Res. 2015;30:2140–2149. doi: 10.1002/jbmr.2735.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jbmr.2735</ArticleId>
            <ArticleId IdType="pmc">PMC4876707</ArticleId>
            <ArticleId IdType="pubmed">26531055</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Butler M.T., Wallingford J.B. Planar Cell Polarity in Development and Disease. Nat. Rev. Mol. Cell Biol. 2017;18:375–388. doi: 10.1038/nrm.2017.11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrm.2017.11</ArticleId>
            <ArticleId IdType="pmc">PMC5826606</ArticleId>
            <ArticleId IdType="pubmed">28293032</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang Y., Mlodzik M. Wnt-Frizzled/Planar Cell Polarity Signaling: Cellular Orientation by Facing the Wind (Wnt) Annu. Rev. Cell Dev. Biol. 2015;31:623–646. doi: 10.1146/annurev-cellbio-100814-125315.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev-cellbio-100814-125315</ArticleId>
            <ArticleId IdType="pmc">PMC4673888</ArticleId>
            <ArticleId IdType="pubmed">26566118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sebbagh M., Borg J.-P. Insight into Planar Cell Polarity. Exp. Cell Res. 2014;328:284–295. doi: 10.1016/j.yexcr.2014.09.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.yexcr.2014.09.005</ArticleId>
            <ArticleId IdType="pubmed">25236701</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao B., Song H., Bishop K., Elliot G., Garrett L., English M., Andre P., Robinson J., Sood R., Minami Y., et al.  Wnt Signaling Gradients Establish Planar Cell Polarity by Inducing Vangl2 Phosphorylation through Ror2. Dev. Cell. 2011;20:163–176. doi: 10.1016/j.devcel.2011.01.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.devcel.2011.01.001</ArticleId>
            <ArticleId IdType="pmc">PMC3062198</ArticleId>
            <ArticleId IdType="pubmed">21316585</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andre P., Wang Q., Wang N., Gao B., Schilit A., Halford M.M., Stacker S.A., Zhang X., Yang Y. The Wnt Coreceptor Ryk Regulates Wnt/Planar Cell Polarity by Modulating the Degradation of the Core Planar Cell Polarity Component Vangl2. J. Biol. Chem. 2012;287:44518–44525. doi: 10.1074/jbc.M112.414441.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M112.414441</ArticleId>
            <ArticleId IdType="pmc">PMC3531765</ArticleId>
            <ArticleId IdType="pubmed">23144463</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Macheda M.L., Sun W.W., Kugathasan K., Hogan B.M., Bower N.I., Halford M.M., Zhang Y.F., Jacques B.E., Lieschke G.J., Dabdoub A., et al.  The Wnt Receptor Ryk Plays a Role in Mammalian Planar Cell Polarity Signaling. J. Biol. Chem. 2012;287:29312–29323. doi: 10.1074/jbc.M112.362681.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M112.362681</ArticleId>
            <ArticleId IdType="pmc">PMC3436188</ArticleId>
            <ArticleId IdType="pubmed">22773843</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ho H.-Y.H., Susman M.W., Bikoff J.B., Ryu Y.K., Jonas A.M., Hu L., Kuruvilla R., Greenberg M.E. Wnt5a–Ror–Dishevelled Signaling Constitutes a Core Developmental Pathway That Controls Tissue Morphogenesis. Proc. Natl. Acad. Sci. USA. 2012;109:4044–4051. doi: 10.1073/pnas.1200421109.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1200421109</ArticleId>
            <ArticleId IdType="pmc">PMC3306699</ArticleId>
            <ArticleId IdType="pubmed">22343533</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Struhl G., Casal J., Lawrence P.A. Dissecting the Molecular Bridges That Mediate the Function of Frizzled in Planar Cell Polarity. Development. 2012;139:3665–3674. doi: 10.1242/dev.083550.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.083550</ArticleId>
            <ArticleId IdType="pmc">PMC3436116</ArticleId>
            <ArticleId IdType="pubmed">22949620</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen W.-S., Antic D., Matis M., Logan C.Y., Povelones M., Anderson G.A., Nusse R., Axelrod J.D. Asymmetric Homotypic Interactions of the Atypical Cadherin Flamingo Mediate Intercellular Polarity Signaling. Cell. 2008;133:1093–1105. doi: 10.1016/j.cell.2008.04.048.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2008.04.048</ArticleId>
            <ArticleId IdType="pmc">PMC2446404</ArticleId>
            <ArticleId IdType="pubmed">18555784</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao B.  Chapter Eleven—Wnt Regulation of Planar Cell Polarity (PCP) In: Yang Y., editor. Planar Cell Polarity During Development. Volume 101. Academic Press; Cambridge, MA, USA: 2012. pp. 263–295. Current Topics in Developmental Biology.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang B., Sinha T., Jiao K., Serra R., Wang J. Disruption of PCP Signaling Causes Limb Morphogenesis and Skeletal Defects and May Underlie Robinow Syndrome and Brachydactyly Type B. Hum. Mol. Genet. 2011;20:271–285. doi: 10.1093/hmg/ddq462.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddq462</ArticleId>
            <ArticleId IdType="pmc">PMC3031336</ArticleId>
            <ArticleId IdType="pubmed">20962035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Y., Dudley A.T. Noncanonical Frizzled Signaling Regulates Cell Polarity of Growth Plate Chondrocytes. Development. 2009;136:1083–1092. doi: 10.1242/dev.023820.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.023820</ArticleId>
            <ArticleId IdType="pmc">PMC2685929</ArticleId>
            <ArticleId IdType="pubmed">19224985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gavin B.J., McMahon J.A., McMahon A.P. Expression of Multiple Novel Wnt-1/Int-1-Related Genes during Fetal and Adult Mouse Development. Genes Dev. 1990;4:2319–2332. doi: 10.1101/gad.4.12b.2319.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gad.4.12b.2319</ArticleId>
            <ArticleId IdType="pubmed">2279700</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamaguchi T.P., Bradley A., McMahon A.P., Jones S. A Wnt5a Pathway Underlies Outgrowth of Multiple Structures in the Vertebrate Embryo. Development. 1999;126:1211–1223. doi: 10.1242/dev.126.6.1211.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.126.6.1211</ArticleId>
            <ArticleId IdType="pubmed">10021340</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hopyan S., Sharpe J., Yang Y. Budding Behaviors: Growth of the Limb as a Model of Morphogenesis. Dev. Dyn. 2011;240:1054–1062. doi: 10.1002/dvdy.22601.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/dvdy.22601</ArticleId>
            <ArticleId IdType="pubmed">21384474</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Galea G.L., Meakin L.B., Savery D., Taipaleenmaki H., Delisser P., Stein G.S., Copp A.J., van Wijnen A.J., Lanyon L.E., Price J.S. Planar Cell Polarity Aligns Osteoblast Division in Response to Substrate Strain. J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 2015;30:423–435. doi: 10.1002/jbmr.2377.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jbmr.2377</ArticleId>
            <ArticleId IdType="pmc">PMC4333081</ArticleId>
            <ArticleId IdType="pubmed">25264362</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wan Y., Lantz B., Cusack B.J., Szabo-Rogers H.L. Prickle1 Regulates Differentiation of Frontal Bone Osteoblasts. Sci. Rep. 2018;8:18021. doi: 10.1038/s41598-018-36742-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-018-36742-0</ArticleId>
            <ArticleId IdType="pmc">PMC6303328</ArticleId>
            <ArticleId IdType="pubmed">30575813</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bikkavilli R.K., Feigin M.E., Malbon C.C. Gαo Mediates WNT-JNK Signaling through Dishevelled 1 and 3, RhoA Family Members, and MEKK 1 and 4 in Mammalian Cells. J. Cell Sci. 2008;121:234–245. doi: 10.1242/jcs.021964.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/jcs.021964</ArticleId>
            <ArticleId IdType="pubmed">18187455</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ridley A.J., Hall A. The Small GTP-Binding Protein Rho Regulates the Assembly of Focal Adhesions and Actin Stress Fibers in Response to Growth Factors. Cell. 1992;70:389–399. doi: 10.1016/0092-8674(92)90163-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0092-8674(92)90163-7</ArticleId>
            <ArticleId IdType="pubmed">1643657</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McBeath R., Pirone D.M., Nelson C.M., Bhadriraju K., Chen C.S. Cell Shape, Cytoskeletal Tension, and RhoA Regulate Stem Cell Lineage Commitment. Dev. Cell. 2004;6:483–495. doi: 10.1016/S1534-5807(04)00075-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1534-5807(04)00075-9</ArticleId>
            <ArticleId IdType="pubmed">15068789</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ridley A.J., Paterson H.F., Johnston C.L., Diekmann D., Hall A. The Small GTP-Binding Protein Rac Regulates Growth Factor-Induced Membrane Ruffling. Cell. 1992;70:401–410. doi: 10.1016/0092-8674(92)90164-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0092-8674(92)90164-8</ArticleId>
            <ArticleId IdType="pubmed">1643658</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Santos A., Bakker A.D., de Blieck-Hogervorst J.M.A., Klein-Nulend J. WNT5A Induces Osteogenic Differentiation of Human Adipose Stem Cells via Rho-Associated Kinase Rock. Cytotherapy. 2010;12:924–932. doi: 10.3109/14653241003774011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/14653241003774011</ArticleId>
            <ArticleId IdType="pubmed">20429785</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kassem M., Marie P.J. Senescence-Associated Intrinsic Mechanisms of Osteoblast Dysfunctions. Aging Cell. 2011;10:191–197. doi: 10.1111/j.1474-9726.2011.00669.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1474-9726.2011.00669.x</ArticleId>
            <ArticleId IdType="pubmed">21210937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang D., Udagawa N., Nakamura I., Murakami H., Saito S., Yamasaki K., Shibasaki Y., Morii N., Narumiya S., Takahashi N. The Small GTP-Binding Protein, Rho P21, Is Involved in Bone Resorption by Regulating Cytoskeletal Organization in Osteoclasts. J. Cell Sci. 1995;108:2285–2292. doi: 10.1242/jcs.108.6.2285.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/jcs.108.6.2285</ArticleId>
            <ArticleId IdType="pubmed">7673348</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chellaiah M.A., Soga N., Swanson S., McAllister S., Alvarez U., Wang D., Dowdy S.F., Hruska K.A. Rho-A Is Critical for Osteoclast Podosome Organization, Motility, and Bone Resorption. J. Biol. Chem. 2000;275:11993–12002. doi: 10.1074/jbc.275.16.11993.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.275.16.11993</ArticleId>
            <ArticleId IdType="pubmed">10766830</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ory S., Munari-Silem Y., Fort P., Jurdic P. Rho and Rac Exert Antagonistic Functions on Spreading of Macrophage-Derived Multinucleated Cells and Are Not Required for Actin Fiber Formation. J. Cell Sci. 2000;113:1177–1188. doi: 10.1242/jcs.113.7.1177.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/jcs.113.7.1177</ArticleId>
            <ArticleId IdType="pubmed">10704369</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thompson M., Nejak-Bowen K., Monga S.P.S.  Crosstalk of the Wnt Signaling Pathway. In: Goss K.H., Kahn M., editors. Targeting the Wnt Pathway in Cancer. Springer; New York, NY, USA: 2011. pp. 51–80.</Citation>
        </Reference>
        <Reference>
          <Citation>Itasaki N., Hoppler S. Crosstalk between Wnt and Bone Morphogenic Protein Signaling: A Turbulent Relationship. Dev. Dyn. 2010;239:16–33. doi: 10.1002/dvdy.22009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/dvdy.22009</ArticleId>
            <ArticleId IdType="pubmed">19544585</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nemoto E., Ebe Y., Kanaya S., Tsuchiya M., Nakamura T., Tamura M., Shimauchi H. Wnt5a Signaling Is a Substantial Constituent in Bone Morphogenetic Protein-2-Mediated Osteoblastogenesis. Biochem. Biophys. Res. Commun. 2012;422:627–632. doi: 10.1016/j.bbrc.2012.05.039.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2012.05.039</ArticleId>
            <ArticleId IdType="pubmed">22609204</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee S., Remark L.H., Josephson A.M., Leclerc K., Lopez E.M., Kirby D.J., Mehta D., Litwa H.P., Wong M.Z., Shin S.Y., et al.  Notch-Wnt Signal Crosstalk Regulates Proliferation and Differentiation of Osteoprogenitor Cells during Intramembranous Bone Healing. NPJ Regen. Med. 2021;6:29. doi: 10.1038/s41536-021-00139-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41536-021-00139-x</ArticleId>
            <ArticleId IdType="pmc">PMC8163848</ArticleId>
            <ArticleId IdType="pubmed">34050174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu H., Hilton M.J., Tu X., Yu K., Ornitz D.M., Long F. Sequential Roles of Hedgehog and Wnt Signaling in Osteoblast Development. Development. 2005;132:49–60. doi: 10.1242/dev.01564.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.01564</ArticleId>
            <ArticleId IdType="pubmed">15576404</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mak K.K., Bi Y., Wan C., Chuang P.-T., Clemens T., Young M., Yang Y. Hedgehog Signaling in Mature Osteoblasts Regulates Bone Formation and Resorption by Controlling PTHrP and RANKL Expression. Dev. Cell. 2008;14:674–688. doi: 10.1016/j.devcel.2008.02.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.devcel.2008.02.003</ArticleId>
            <ArticleId IdType="pubmed">18477451</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boonanantanasarn K., Lee H.-L., Baek K., Woo K.M., Ryoo H.-M., Baek J.-H., Kim G.-S. EGF Inhibits Wnt/β-Catenin-Induced Osteoblast Differentiation by Promoting β-Catenin Degradation. J. Cell. Biochem. 2015;116:2849–2857. doi: 10.1002/jcb.25231.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcb.25231</ArticleId>
            <ArticleId IdType="pubmed">26015066</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wada T., Nakashima T., Hiroshi N., Penninger J.M. RANKL–RANK Signaling in Osteoclastogenesis and Bone Disease. Trends Mol. Med. 2006;12:17–25. doi: 10.1016/j.molmed.2005.11.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molmed.2005.11.007</ArticleId>
            <ArticleId IdType="pubmed">16356770</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boyce B.F., Xing L. Biology of RANK, RANKL, and Osteoprotegerin. Arthritis Res. 2007;9:S1. doi: 10.1186/ar2165.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/ar2165</ArticleId>
            <ArticleId IdType="pmc">PMC1924516</ArticleId>
            <ArticleId IdType="pubmed">17634140</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kieslinger M., Folberth S., Dobreva G., Dorn T., Croci L., Erben R., Consalez G.G., Grosschedl R. EBF2 Regulates Osteoblast-Dependent Differentiation of Osteoclasts. Dev. Cell. 2005;9:757–767. doi: 10.1016/j.devcel.2005.10.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.devcel.2005.10.009</ArticleId>
            <ArticleId IdType="pubmed">16326388</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boyce B.F., Xing L., Chen D. Osteoprotegerin, the Bone Protector, Is a Surprising Target for β-Catenin Signaling. Cell Metab. 2005;2:344–345. doi: 10.1016/j.cmet.2005.11.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2005.11.011</ArticleId>
            <ArticleId IdType="pmc">PMC2647984</ArticleId>
            <ArticleId IdType="pubmed">16330319</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spencer G.J., Utting J.C., Etheridge S.L., Arnett T.R., Genever P.G. Wnt Signalling in Osteoblasts Regulates Expression of the Receptor Activator of NFkappaB Ligand and Inhibits Osteoclastogenesis in Vitro. J. Cell Sci. 2006;119:1283–1296. doi: 10.1242/jcs.02883.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/jcs.02883</ArticleId>
            <ArticleId IdType="pubmed">16522681</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li M., Wang H., Huang T., Wang J., Ding Y., Li Z., Zhang J., Li L. TAB2 Scaffolds TAK1 and NLK in Repressing Canonical Wnt Signaling. J. Biol. Chem. 2010;285:13397–13404. doi: 10.1074/jbc.M109.083246.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M109.083246</ArticleId>
            <ArticleId IdType="pmc">PMC2859499</ArticleId>
            <ArticleId IdType="pubmed">20194509</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saxton R.A., Sabatini D.M. MTOR Signaling in Growth, Metabolism, and Disease. Cell. 2017;168:960–976. doi: 10.1016/j.cell.2017.02.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2017.02.004</ArticleId>
            <ArticleId IdType="pmc">PMC5394987</ArticleId>
            <ArticleId IdType="pubmed">28283069</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Russell R.C., Fang C., Guan K.-L. An Emerging Role for TOR Signaling in Mammalian Tissue and Stem Cell Physiology. Development. 2011;138:3343–3356. doi: 10.1242/dev.058230.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.058230</ArticleId>
            <ArticleId IdType="pmc">PMC3143559</ArticleId>
            <ArticleId IdType="pubmed">21791526</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen J., Long F. MTORC1 Signaling Promotes Osteoblast Differentiation from Preosteoblasts. PLoS ONE. 2015;10:e0130627.  doi: 10.1371/journal.pone.0130627.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0130627</ArticleId>
            <ArticleId IdType="pmc">PMC4474698</ArticleId>
            <ArticleId IdType="pubmed">26090674</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen J., Holguin N., Shi Y., Silva M.J., Long F. MTORC2 Signaling Promotes Skeletal Growth and Bone Formation in Mice. J. Bone Min. Res. 2015;30:369–378. doi: 10.1002/jbmr.2348.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jbmr.2348</ArticleId>
            <ArticleId IdType="pmc">PMC4322759</ArticleId>
            <ArticleId IdType="pubmed">25196701</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen J., Long F. MTORC1 Signaling Controls Mammalian Skeletal Growth through Stimulation of Protein Synthesis. Development. 2014;141:2848–2854. doi: 10.1242/dev.108811.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.108811</ArticleId>
            <ArticleId IdType="pmc">PMC4197614</ArticleId>
            <ArticleId IdType="pubmed">24948603</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin C., Liu L., Zeng C., Cui Z.-K., Chen Y., Lai P., Wang H., Shao Y., Zhang H., Zhang R., et al.  Activation of MTORC1 in Subchondral Bone Preosteoblasts Promotes Osteoarthritis by Stimulating Bone Sclerosis and Secretion of CXCL12. Bone Res. 2019;7:5. doi: 10.1038/s41413-018-0041-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41413-018-0041-8</ArticleId>
            <ArticleId IdType="pmc">PMC6381187</ArticleId>
            <ArticleId IdType="pubmed">30792936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen H., Ji X., Lee W.-C., Shi Y., Li B., Abel E.D., Jiang D., Huang W., Long F. Increased Glycolysis Mediates Wnt7b-Induced Bone Formation. FASEB J. 2019;33:7810–7821. doi: 10.1096/fj.201900201RR.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1096/fj.201900201RR</ArticleId>
            <ArticleId IdType="pmc">PMC6593878</ArticleId>
            <ArticleId IdType="pubmed">30913395</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee W.-C., Guntur A.R., Long F., Rosen C.J. Energy Metabolism of the Osteoblast: Implications for Osteoporosis. Endocr. Rev. 2017;38:255–266. doi: 10.1210/er.2017-00064.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/er.2017-00064</ArticleId>
            <ArticleId IdType="pmc">PMC5460680</ArticleId>
            <ArticleId IdType="pubmed">28472361</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yan B., Zhang Z., Jin D., Cai C., Jia C., Liu W., Wang T., Li S., Zhang H., Huang B., et al.  MTORC1 Regulates PTHrP to Coordinate Chondrocyte Growth, Proliferation and Differentiation. Nat. Commun. 2016;7:11151. doi: 10.1038/ncomms11151.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncomms11151</ArticleId>
            <ArticleId IdType="pmc">PMC4822018</ArticleId>
            <ArticleId IdType="pubmed">27039827</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiang X., Zhao J., Xu G., Li Y., Zhang W. MTOR and the Differentiation of Mesenchymal Stem Cells. Acta Biochim. Biophys. Sin. 2011;43:501–510. doi: 10.1093/abbs/gmr041.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/abbs/gmr041</ArticleId>
            <ArticleId IdType="pubmed">21642276</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Y., Xu S., Li K., Tan K., Liang K., Wang J., Shen J., Zou W., Hu L., Cai D., et al.  MTORC1 Inhibits NF-ΚB/NFATc1 Signaling and Prevents Osteoclast Precursor Differentiation, In Vitro and In Mice. J. Bone Miner. Res. 2017;32:1829–1840. doi: 10.1002/jbmr.3172.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jbmr.3172</ArticleId>
            <ArticleId IdType="pubmed">28520214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singha U.K., Jiang Y., Yu S., Luo M., Lu Y., Zhang J., Xiao G. Rapamycin Inhibits Osteoblast Proliferation and Differentiation in MC3T3-E1 Cells and Primary Mouse Bone Marrow Stromal Cells. J. Cell. Biochem. 2008;103:434–446. doi: 10.1002/jcb.21411.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcb.21411</ArticleId>
            <ArticleId IdType="pubmed">17516572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee K.-W., Yook J.-Y., Son M.-Y., Kim M.-J., Koo D.-B., Han Y.-M., Cho Y.S. Rapamycin Promotes the Osteoblastic Differentiation of Human Embryonic Stem Cells by Blocking the MTOR Pathway and Stimulating the BMP/Smad Pathway. Stem Cells Dev. 2010;19:557–568. doi: 10.1089/scd.2009.0147.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/scd.2009.0147</ArticleId>
            <ArticleId IdType="pubmed">19642865</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kichaev G., Bhatia G., Loh P.-R., Gazal S., Burch K., Freund M.K., Schoech A., Pasaniuc B., Price A.L. Leveraging Polygenic Functional Enrichment to Improve GWAS Power. Am. J. Hum. Genet. 2019;104:65–75. doi: 10.1016/j.ajhg.2018.11.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajhg.2018.11.008</ArticleId>
            <ArticleId IdType="pmc">PMC6323418</ArticleId>
            <ArticleId IdType="pubmed">30595370</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kemp J.P., Morris J.A., Medina-Gomez C., Forgetta V., Warrington N.M., Youlten S.E., Zheng J., Gregson C.L., Grundberg E., Trajanoska K., et al.  Identification of 153 New Loci Associated with Heel Bone Mineral Density and Functional Involvement of GPC6 in Osteoporosis. Nat. Genet. 2017;49:1468–1475. doi: 10.1038/ng.3949.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ng.3949</ArticleId>
            <ArticleId IdType="pmc">PMC5621629</ArticleId>
            <ArticleId IdType="pubmed">28869591</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu L., Zhao M., Xie Z.-G., Liu J., Peng H.-P., Pei Y.-F., Sun H.-P., Zhang L. Twelve New Genomic Loci Associated With Bone Mineral Density. Front. Endocrinol. 2020;11:243. doi: 10.3389/fendo.2020.00243.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fendo.2020.00243</ArticleId>
            <ArticleId IdType="pmc">PMC7188784</ArticleId>
            <ArticleId IdType="pubmed">32390946</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim S.K. Identification of 613 New Loci Associated with Heel Bone Mineral Density and a Polygenic Risk Score for Bone Mineral Density, Osteoporosis and Fracture. PLoS ONE. 2018;13:e0200785.  doi: 10.1371/journal.pone.0200785.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0200785</ArticleId>
            <ArticleId IdType="pmc">PMC6062019</ArticleId>
            <ArticleId IdType="pubmed">30048462</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karner C.M., Esen E., Chen J., Hsu F.-F., Turk J., Long F. Wnt Protein Signaling Reduces Nuclear Acetyl-CoA Levels to Suppress Gene Expression during Osteoblast Differentiation. J. Biol. Chem. 2016;291:13028–13039. doi: 10.1074/jbc.M115.708578.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M115.708578</ArticleId>
            <ArticleId IdType="pmc">PMC4933220</ArticleId>
            <ArticleId IdType="pubmed">27129247</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dai Q., Xu Z., Ma X., Niu N., Zhou S., Xie F., Jiang L., Wang J., Zou W. MTOR/Raptor Signaling Is Critical for Skeletogenesis in Mice through the Regulation of Runx2 Expression. Cell Death Differ. 2017;24:1886–1899. doi: 10.1038/cdd.2017.110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/cdd.2017.110</ArticleId>
            <ArticleId IdType="pmc">PMC5635215</ArticleId>
            <ArticleId IdType="pubmed">28686577</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martin S.K., Fitter S., Dutta A.K., Matthews M.P., Walkley C.R., Hall M.N., Ruegg M.A., Gronthos S., Zannettino A.C.W. Brief Report: The Differential Roles of MTORC1 and MTORC2 in Mesenchymal Stem Cell Differentiation. Stem Cells. 2015;33:1359–1365. doi: 10.1002/stem.1931.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/stem.1931</ArticleId>
            <ArticleId IdType="pubmed">25537496</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zeng H., Lu B., Zamponi R., Yang Z., Wetzel K., Loureiro J., Mohammadi S., Beibel M., Bergling S., Reece-Hoyes J., et al.  MTORC1 Signaling Suppresses Wnt/β-Catenin Signaling through DVL-Dependent Regulation of Wnt Receptor FZD Level. Proc. Natl. Acad. Sci. USA. 2018;115:E10362–E10369. doi: 10.1073/pnas.1808575115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1808575115</ArticleId>
            <ArticleId IdType="pmc">PMC6217415</ArticleId>
            <ArticleId IdType="pubmed">30297426</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu A., Rual J.-F., Tamai K., Harada Y., Vidal M., He X., Kirchhausen T. Association of Dishevelled with the Clathrin AP-2 Adaptor Is Required for Frizzled Endocytosis and Planar Cell Polarity Signaling. Dev. Cell. 2007;12:129–141. doi: 10.1016/j.devcel.2006.10.015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.devcel.2006.10.015</ArticleId>
            <ArticleId IdType="pmc">PMC2831292</ArticleId>
            <ArticleId IdType="pubmed">17199046</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dupont S., Morsut L., Aragona M., Enzo E., Giulitti S., Cordenonsi M., Zanconato F., Le Digabel J., Forcato M., Bicciato S., et al.  Role of YAP/TAZ in Mechanotransduction. Nature. 2011;474:179–183. doi: 10.1038/nature10137.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature10137</ArticleId>
            <ArticleId IdType="pubmed">21654799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Halder G., Dupont S., Piccolo S. Transduction of Mechanical and Cytoskeletal Cues by YAP and TAZ. Nat. Rev. Mol. Cell Biol. 2012;13:591–600. doi: 10.1038/nrm3416.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrm3416</ArticleId>
            <ArticleId IdType="pubmed">22895435</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Varelas X., Sakuma R., Samavarchi-Tehrani P., Peerani R., Rao B.M., Dembowy J., Yaffe M.B., Zandstra P.W., Wrana J.L. TAZ Controls Smad Nucleocytoplasmic Shuttling and Regulates Human Embryonic Stem-Cell Self-Renewal. Nat. Cell Biol. 2008;10:837–848. doi: 10.1038/ncb1748.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncb1748</ArticleId>
            <ArticleId IdType="pubmed">18568018</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alarcón C., Zaromytidou A.-I., Xi Q., Gao S., Yu J., Fujisawa S., Barlas A., Miller A.N., Manova-Todorova K., Macias M.J., et al.  Nuclear CDKs Drive Smad Transcriptional Activation and Turnover in BMP and TGF-Beta Pathways. Cell. 2009;139:757–769. doi: 10.1016/j.cell.2009.09.035.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2009.09.035</ArticleId>
            <ArticleId IdType="pmc">PMC2818353</ArticleId>
            <ArticleId IdType="pubmed">19914168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Azzolin L., Panciera T., Soligo S., Enzo E., Bicciato S., Dupont S., Bresolin S., Frasson C., Basso G., Guzzardo V., et al.  YAP/TAZ Incorporation in the β-Catenin Destruction Complex Orchestrates the Wnt Response. Cell. 2014;158:157–170. doi: 10.1016/j.cell.2014.06.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2014.06.013</ArticleId>
            <ArticleId IdType="pubmed">24976009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Azzolin L., Zanconato F., Bresolin S., Forcato M., Basso G., Bicciato S., Cordenonsi M., Piccolo S. Role of TAZ as Mediator of Wnt Signaling. Cell. 2012;151:1443–1456. doi: 10.1016/j.cell.2012.11.027.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2012.11.027</ArticleId>
            <ArticleId IdType="pubmed">23245942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Byun M.R., Hwang J.-H., Kim A.R., Kim K.M., Hwang E.S., Yaffe M.B., Hong J.-H. Canonical Wnt Signalling Activates TAZ through PP1A during Osteogenic Differentiation. Cell Death Differ. 2014;21:854–863. doi: 10.1038/cdd.2014.8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/cdd.2014.8</ArticleId>
            <ArticleId IdType="pmc">PMC4013522</ArticleId>
            <ArticleId IdType="pubmed">24510127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Piccolo S., Dupont S., Cordenonsi M. The Biology of YAP/TAZ: Hippo Signaling and Beyond. Physiol. Rev. 2014;94:1287–1312. doi: 10.1152/physrev.00005.2014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/physrev.00005.2014</ArticleId>
            <ArticleId IdType="pubmed">25287865</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zaidi S.K., Sullivan A.J., Medina R., Ito Y., van Wijnen A.J., Stein J.L., Lian J.B., Stein G.S. Tyrosine Phosphorylation Controls Runx2-Mediated Subnuclear Targeting of YAP to Repress Transcription. EMBO J. 2004;23:790–799. doi: 10.1038/sj.emboj.7600073.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.emboj.7600073</ArticleId>
            <ArticleId IdType="pmc">PMC380991</ArticleId>
            <ArticleId IdType="pubmed">14765127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hong J.-H., Hwang E.S., McManus M.T., Amsterdam A., Tian Y., Kalmukova R., Mueller E., Benjamin T., Spiegelman B.M., Sharp P.A., et al.  TAZ, a Transcriptional Modulator of Mesenchymal Stem Cell Differentiation. Science. 2005;309:1074–1078. doi: 10.1126/science.1110955.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1110955</ArticleId>
            <ArticleId IdType="pubmed">16099986</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pan J.-X., Xiong L., Zhao K., Zeng P., Wang B., Tang F.-L., Sun D., Guo H., Yang X., Cui S., et al.  YAP Promotes Osteogenesis and Suppresses Adipogenic Differentiation by Regulating β-Catenin Signaling. Bone Res. 2018;6:18. doi: 10.1038/s41413-018-0018-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41413-018-0018-7</ArticleId>
            <ArticleId IdType="pmc">PMC5984632</ArticleId>
            <ArticleId IdType="pubmed">29872550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang W., Han W., Qin A., Wang Z., Xu J., Qian Y. The Emerging Role of Hippo Signaling Pathway in Regulating Osteoclast Formation. J. Cell. Physiol. 2018;233:4606–4617. doi: 10.1002/jcp.26372.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcp.26372</ArticleId>
            <ArticleId IdType="pubmed">29219182</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Varelas X., Miller B.W., Sopko R., Song S., Gregorieff A., Fellouse F.A., Sakuma R., Pawson T., Hunziker W., McNeill H., et al.  The Hippo Pathway Regulates Wnt/Beta-Catenin Signaling. Dev. Cell. 2010;18:579–591. doi: 10.1016/j.devcel.2010.03.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.devcel.2010.03.007</ArticleId>
            <ArticleId IdType="pubmed">20412773</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deng F., Peng L., Li Z., Tan G., Liang E., Chen S., Zhao X., Zhi F. YAP Triggers the Wnt/β-Catenin Signalling Pathway and Promotes Enterocyte Self-Renewal, Regeneration and Tumorigenesis after DSS-Induced Injury. Cell Death Dis. 2018;9:1–16. doi: 10.1038/s41419-017-0244-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41419-017-0244-8</ArticleId>
            <ArticleId IdType="pmc">PMC5833613</ArticleId>
            <ArticleId IdType="pubmed">29396428</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park H.W., Kim Y.C., Yu B., Moroishi T., Mo J.-S., Plouffe S.W., Meng Z., Lin K.C., Yu F.-X., Alexander C.M., et al.  Alternative Wnt Signaling Activates YAP/TAZ. Cell. 2015;162:780–794. doi: 10.1016/j.cell.2015.07.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2015.07.013</ArticleId>
            <ArticleId IdType="pmc">PMC4538707</ArticleId>
            <ArticleId IdType="pubmed">26276632</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodríguez-Carballo E., Gámez B., Ventura F. P38 MAPK Signaling in Osteoblast Differentiation. Front. Cell Dev. Biol. 2016;4:40. doi: 10.3389/fcell.2016.00040.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fcell.2016.00040</ArticleId>
            <ArticleId IdType="pmc">PMC4858538</ArticleId>
            <ArticleId IdType="pubmed">27200351</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jaiswal R.K., Jaiswal N., Bruder S.P., Mbalaviele G., Marshak D.R., Pittenger M.F. Adult Human Mesenchymal Stem Cell Differentiation to the Osteogenic or Adipogenic Lineage Is Regulated by Mitogen-Activated Protein Kinase. J. Biol. Chem. 2000;275:9645–9652. doi: 10.1074/jbc.275.13.9645.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.275.13.9645</ArticleId>
            <ArticleId IdType="pubmed">10734116</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gallea S., Lallemand F., Atfi A., Rawadi G., Ramez V., Spinella-Jaegle S., Kawai S., Faucheu C., Huet L., Baron R., et al.  Activation of Mitogen-Activated Protein Kinase Cascades Is Involved in Regulation of Bone Morphogenetic Protein-2-Induced Osteoblast Differentiation in Pluripotent C2C12 Cells. Bone. 2001;28:491–498. doi: 10.1016/S8756-3282(01)00415-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S8756-3282(01)00415-X</ArticleId>
            <ArticleId IdType="pubmed">11344048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guicheux J., Lemonnier J., Ghayor C., Suzuki A., Palmer G., Caverzasio J. Activation of P38 Mitogen-Activated Protein Kinase and c-Jun-NH2-Terminal Kinase by BMP-2 and Their Implication in the Stimulation of Osteoblastic Cell Differentiation. J. Bone Min. Res. 2003;18:2060–2068. doi: 10.1359/jbmr.2003.18.11.2060.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1359/jbmr.2003.18.11.2060</ArticleId>
            <ArticleId IdType="pubmed">14606520</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suzuki A., Palmer G., Bonjour J.P., Caverzasio J. Regulation of Alkaline Phosphatase Activity by P38 MAP Kinase in Response to Activation of Gi Protein-Coupled Receptors by Epinephrine in Osteoblast-like Cells. Endocrinology. 1999;140:3177–3182. doi: 10.1210/endo.140.7.6857.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/endo.140.7.6857</ArticleId>
            <ArticleId IdType="pubmed">10385412</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yun M.-S., Kim S.-E., Jeon S.H., Lee J.-S., Choi K.-Y. Both ERK and Wnt/Beta-Catenin Pathways Are Involved in Wnt3a-Induced Proliferation. J. Cell Sci. 2005;118:313–322. doi: 10.1242/jcs.01601.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/jcs.01601</ArticleId>
            <ArticleId IdType="pubmed">15615777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suzuki A., Guicheux J., Palmer G., Miura Y., Oiso Y., Bonjour J.P., Caverzasio J. Evidence for a Role of P38 MAP Kinase in Expression of Alkaline Phosphatase during Osteoblastic Cell Differentiation. Bone. 2002;30:91–98. doi: 10.1016/S8756-3282(01)00660-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S8756-3282(01)00660-3</ArticleId>
            <ArticleId IdType="pubmed">11792570</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Y., Pizzute T., Pei M. A Review of Crosstalk between MAPK and Wnt Signals and Its Impact on Cartilage Regeneration. Cell Tissue Res. 2014;358:633–649. doi: 10.1007/s00441-014-2010-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00441-014-2010-x</ArticleId>
            <ArticleId IdType="pmc">PMC4234693</ArticleId>
            <ArticleId IdType="pubmed">25312291</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jeong W.-J., Yoon J., Park J.-C., Lee S.-H., Lee S.-H., Kaduwal S., Kim H., Yoon J.-B., Choi K.-Y. Ras Stabilization through Aberrant Activation of Wnt/β-Catenin Signaling Promotes Intestinal Tumorigenesis. Sci. Signal. 2012;5:ra30. doi: 10.1126/scisignal.2002242.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/scisignal.2002242</ArticleId>
            <ArticleId IdType="pubmed">22494971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Červenka I., Wolf J., Mašek J., Krejci P., Wilcox W.R., Kozubík A., Schulte G., Gutkind J.S., Bryja V. Mitogen-Activated Protein Kinases Promote WNT/Beta-Catenin Signaling via Phosphorylation of LRP6. Mol. Cell Biol. 2011;31:179–189. doi: 10.1128/MCB.00550-10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/MCB.00550-10</ArticleId>
            <ArticleId IdType="pmc">PMC3019858</ArticleId>
            <ArticleId IdType="pubmed">20974802</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haÿ E., Nouraud A., Marie P.J. N-Cadherin Negatively Regulates Osteoblast Proliferation and Survival by Antagonizing Wnt, ERK and PI3K/Akt Signalling. PLoS ONE. 2009;4:e8284.  doi: 10.1371/journal.pone.0008284.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0008284</ArticleId>
            <ArticleId IdType="pmc">PMC2788421</ArticleId>
            <ArticleId IdType="pubmed">20011526</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koyama H., Nakade O., Takada Y., Kaku T., Lau K.H.W. Melatonin at Pharmacologic Doses Increases Bone Mass by Suppressing Resorption through Down-Regulation of the RANKL-Mediated Osteoclast Formation and Activation. J. Bone Min. Res. 2002;17:1219–1229. doi: 10.1359/jbmr.2002.17.7.1219.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1359/jbmr.2002.17.7.1219</ArticleId>
            <ArticleId IdType="pubmed">12096835</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Satomura K., Tobiume S., Tokuyama R., Yamasaki Y., Kudoh K., Maeda E., Nagayama M. Melatonin at Pharmacological Doses Enhances Human Osteoblastic Differentiation in Vitro and Promotes Mouse Cortical Bone Formation in Vivo. J. Pineal Res. 2007;42:231–239. doi: 10.1111/j.1600-079X.2006.00410.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1600-079X.2006.00410.x</ArticleId>
            <ArticleId IdType="pubmed">17349020</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roth J.A., Kim B.G., Lin W.L., Cho M.I. Melatonin Promotes Osteoblast Differentiation and Bone Formation. J. Biol. Chem. 1999;274:22041–22047. doi: 10.1074/jbc.274.31.22041.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.274.31.22041</ArticleId>
            <ArticleId IdType="pubmed">10419530</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li X., Li Z., Wang J., Li Z., Cui H., Dai G., Chen S., Zhang M., Zheng Z., Zhan Z., et al.  Wnt4 Signaling Mediates Protective Effects of Melatonin on New Bone Formation in an Inflammatory Environment. FASEB J. 2019;33:10126–10139. doi: 10.1096/fj.201900093RR.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1096/fj.201900093RR</ArticleId>
            <ArticleId IdType="pubmed">31216173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Radio N.M., Doctor J.S., Witt-Enderby P.A. Melatonin Enhances Alkaline Phosphatase Activity in Differentiating Human Adult Mesenchymal Stem Cells Grown in Osteogenic Medium via MT2 Melatonin Receptors and the MEK/ERK (1/2) Signaling Cascade. J. Pineal Res. 2006;40:332–342. doi: 10.1111/j.1600-079X.2006.00318.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1600-079X.2006.00318.x</ArticleId>
            <ArticleId IdType="pubmed">16635021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park K.-H., Kang J.W., Lee E.-M., Kim J.S., Rhee Y.H., Kim M., Jeong S.J., Park Y.G., Kim S.H. Melatonin Promotes Osteoblastic Differentiation through the BMP/ERK/Wnt Signaling Pathways. J. Pineal Res. 2011;51:187–194. doi: 10.1111/j.1600-079X.2011.00875.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1600-079X.2011.00875.x</ArticleId>
            <ArticleId IdType="pubmed">21470302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Afzal A.R., Jeffery S. One Gene, Two Phenotypes: ROR2 Mutations in Autosomal Recessive Robinow Syndrome and Autosomal Dominant Brachydactyly Type B. Hum. Mutat. 2003;22:1–11. doi: 10.1002/humu.10233.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/humu.10233</ArticleId>
            <ArticleId IdType="pubmed">12815588</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schwarzer W., Witte F., Rajab A., Mundlos S., Stricker S. A Gradient of ROR2 Protein Stability and Membrane Localization Confers Brachydactyly Type B or Robinow Syndrome Phenotypes. Hum. Mol. Genet. 2009;18:4013–4021. doi: 10.1093/hmg/ddp345.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddp345</ArticleId>
            <ArticleId IdType="pubmed">19640924</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>White J.J., Mazzeu J.F., Coban-Akdemir Z., Bayram Y., Bahrambeigi V., Hoischen A., van Bon B.W.M., Gezdirici A., Gulec E.Y., Ramond F., et al.  WNT Signaling Perturbations Underlie the Genetic Heterogeneity of Robinow Syndrome. Am. J. Hum. Genet. 2018;102:27–43. doi: 10.1016/j.ajhg.2017.10.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajhg.2017.10.002</ArticleId>
            <ArticleId IdType="pmc">PMC5777383</ArticleId>
            <ArticleId IdType="pubmed">29276006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Person A.D., Beiraghi S., Sieben C.M., Hermanson S., Neumann A.N., Robu M.E., Schleiffarth J.R., Billington C.J., van Bokhoven H., Hoogeboom J.M., et al.  WNT5A Mutations in Patients with Autosomal Dominant Robinow Syndrome. Dev. Dyn. Off. Publ. Am. Assoc. Anat. 2010;239:327–337. doi: 10.1002/dvdy.22156.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/dvdy.22156</ArticleId>
            <ArticleId IdType="pmc">PMC4059519</ArticleId>
            <ArticleId IdType="pubmed">19918918</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kiper P.O.S., Saito H., Gori F., Unger S., Hesse E., Yamana K., Kiviranta R., Solban N., Liu J., Brommage R., et al.  Cortical-Bone Fragility—Insights from SFRP4 Deficiency in Pyle’s Disease. N. Engl. J. Med. 2016;374:2553–2562. doi: 10.1056/NEJMoa1509342.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa1509342</ArticleId>
            <ArticleId IdType="pmc">PMC5070790</ArticleId>
            <ArticleId IdType="pubmed">27355534</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arboleya L., Queiro R., Alperi M., Lorenzo J.A., Ballina J. Pyle’s Disease: A Human Model of Differentiated Cortical and Trabecular Homeostasis. Reum. Clin. 2020;16:56–58. doi: 10.1016/j.reuma.2018.01.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.reuma.2018.01.002</ArticleId>
            <ArticleId IdType="pubmed">29463445</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen K., Ng P.Y., Chen R., Hu D., Berry S., Baron R., Gori F. Sfrp4 Repression of the Ror2/Jnk Cascade in Osteoclasts Protects Cortical Bone from Excessive Endosteal Resorption. Proc. Natl. Acad. Sci. USA. 2019;116:14138–14143. doi: 10.1073/pnas.1900881116.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1900881116</ArticleId>
            <ArticleId IdType="pmc">PMC6628642</ArticleId>
            <ArticleId IdType="pubmed">31239337</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bodine P.V.N., Stauffer B., Ponce-de-Leon H., Bhat R.A., Mangine A., Seestaller-Wehr L.M., Moran R.A., Billiard J., Fukayama S., Komm B.S., et al.  A Small Molecule Inhibitor of the Wnt Antagonist Secreted Frizzled-Related Protein-1 Stimulates Bone Formation. Bone. 2009;44:1063–1068. doi: 10.1016/j.bone.2009.02.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bone.2009.02.013</ArticleId>
            <ArticleId IdType="pubmed">19254787</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moore W.J., Kern J.C., Bhat R., Commons T.J., Fukayama S., Goljer I., Krishnamurthy G., Magolda R.L., Nogle L., Pitts K., et al.  Modulation of Wnt Signaling through Inhibition of Secreted Frizzled-Related Protein I (SFRP-1) with N-Substituted Piperidinyl Diphenylsulfonyl Sulfonamides. J. Med. Chem. 2009;52:105–116. doi: 10.1021/jm801144h.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/jm801144h</ArticleId>
            <ArticleId IdType="pubmed">19072540</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moore W.J., Kern J.C., Bhat R., Bodine P.V.N., Fukyama S., Krishnamurthy G., Magolda R.L., Pitts K., Stauffer B., Trybulski E.J. Modulation of Wnt Signaling through Inhibition of Secreted Frizzled-Related Protein I (SFRP-1) with N-Substituted Piperidinyl Diphenylsulfonyl Sulfonamides: Part II. Bioorg. Med. Chem. 2010;18:190–201. doi: 10.1016/j.bmc.2009.11.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bmc.2009.11.002</ArticleId>
            <ArticleId IdType="pubmed">19932972</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bodine P.V.N., Zhao W., Kharode Y.P., Bex F.J., Lambert A.-J., Goad M.B., Gaur T., Stein G.S., Lian J.B., Komm B.S. The Wnt Antagonist Secreted Frizzled-Related Protein-1 Is a Negative Regulator of Trabecular Bone Formation in Adult Mice. Mol. Endocrinol. 2004;18:1222–1237. doi: 10.1210/me.2003-0498.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/me.2003-0498</ArticleId>
            <ArticleId IdType="pubmed">14976225</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bovolenta P., Esteve P., Ruiz J.M., Cisneros E., Lopez-Rios J. Beyond Wnt Inhibition: New Functions of Secreted Frizzled-Related Proteins in Development and Disease. J. Cell Sci. 2008;121:737–746. doi: 10.1242/jcs.026096.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/jcs.026096</ArticleId>
            <ArticleId IdType="pubmed">18322270</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
